XOMA Royalty (XOMA) Retained Earnings (2010 - 2026)
XOMA Royalty (XOMA) reported Retained Earnings of -$1.2 billion for Q1 2026, down 1031666.95% on a YoY basis from N/an in Q1 2025, and down 193.26% sequentially from $1.3 billion in Q4 2025.
XOMA Royalty (XOMA) Retained Earnings (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 17 years of Retained Earnings data on file, last reported at -$1.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 1031666.95% year-over-year to -$1.2 billion; the trailing twelve-month figure through Mar 2026 stood at -$1.2 billion (down 1031666.95% YoY), and the FY2025 full-year result was $1.3 billion, up 205.51% from the prior year.
- Retained Earnings retreated to -$1.2 billion in Q1 2026, from $1.3 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.3 billion in Q4 2023 to a low of -$1.2 billion in Q4 2024.
- A 5-year average of $119.0 million and a median of $120000.0 in 2025 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings soared 212.1% in 2022 and plunged 1031666.95% in 2026, its largest moves.
- Tracing XOMA's Retained Earnings over 5 years: stood at $1.3 billion in 2022, then gained by 0.42% to $1.3 billion in 2023, then tumbled by 194.3% to -$1.2 billion in 2024, then jumped by 205.51% to $1.3 billion in 2025, then sank by 193.26% to -$1.2 billion in 2026.
- Business Quant data shows XOMA's Retained Earnings at -$1.2 billion in Q1 2026, $1.3 billion in Q4 2025, and $122000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | -1.22 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.22 Bn |
| Dec 31, 2025 | 1.31 Bn |
| Jun 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | -1.24 Bn |
| Sep 30, 2024 | 104,000.00 |
| Jun 30, 2024 | -1.22 Bn |
| Mar 31, 2024 | -1.23 Bn |
| Dec 31, 2023 | 1.31 Bn |
| Sep 30, 2023 | 1.31 Bn |
| Jun 30, 2023 | 1.31 Bn |
| Mar 31, 2023 | 1.31 Bn |
| Dec 31, 2022 | 1.31 Bn |
| Sep 30, 2022 | -1.18 Bn |
| Jun 30, 2022 | -1.17 Bn |
| Mar 31, 2022 | 1.31 Bn |
| Dec 31, 2021 | -1.17 Bn |
| Sep 30, 2021 | 1.31 Bn |
| Jun 30, 2021 | -1.19 Bn |
| Mar 31, 2021 | 1.27 Bn |